An Infant Formula with Large, Milk Phospholipid-Coated Lipid Droplets Supports Adequate Growth and Is Well-Tolerated in Healthy, Term Asian Infants: A Randomized, Controlled Double-Blind Clinical Trial

被引:13
|
作者
Teoh, Oon Hoe [1 ]
Lin, Tan Pih [1 ]
Abrahamse-Berkeveld, Marieke [2 ]
Winokan, Antoinette [3 ]
Chong, Yap Seng [4 ,5 ,6 ]
Yap, Fabian [1 ]
Marintcheva-Petrova, Maya [2 ]
van der Beek, Eline M. [7 ]
Shek, Lynette P. [4 ,6 ,8 ]
机构
[1] KK Womens & Childrens Hosp, Dept Paediat, Singapore 229899, Singapore
[2] Danone Nutricia Res, NL-3584 CT Utrecht, Netherlands
[3] Nutricia Res, Singapore 138671, Singapore
[4] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore 119228, Singapore
[5] Natl Univ Singapore, Yoo Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore 119228, Singapore
[6] Natl Univ Hlth Syst, Singapore 119228, Singapore
[7] Univ Groningen, Univ Med Ctr Groningen, Dept Paediat, NL-9700 RB Groningen, Netherlands
[8] Natl Univ Signapore, Yoo Loo Lin Sch Med, Dept Pediat, Singapore 119228, Singapore
关键词
lipid droplet structure; safety; growth adequacy; infant formula; FAT GLOBULE-MEMBRANE; GALACTO-OLIGOSACCHARIDES; FRUCTO-OLIGOSACCHARIDES; MIXTURE; ABSORPTION; NUTRITION; EMULSIONS; DIGESTION; SIZES; DIET;
D O I
10.3390/nu14030634
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Lipids are essential for healthy infant growth and development. The structural complexity of lipids in human milk is not present in infant milk formula (IF). A concept IF was developed mimicking more closely the structure and composition of human milk fat globules. The current study evaluates whether a concept IF with large, milk phospholipid-coated lipid droplets (mode diameter 3 to 5 mu m) is equivalent to standard IF with regard to growth adequacy and safety in healthy, term Asian infants. In this randomized, double-blind, controlled trial, infants were randomized after parents decided to introduce formula. Infants received a standard IF with (Control) or without the specific prebiotic mixture scGOS/lcFOS (9:1 ratio; Control w/o prebiotics), or a Concept IF with large, milk phospholipid-coated lipid droplets and the prebiotic mixture. A group of 67 breastfed infants served as a reference. As a priori defined, only those infants who were fully intervention formula-fed <= 28 days of age were included in the equivalence analysis (Control n = 29; Control w/o prebiotics n = 28; Concept n = 35, per-protocol population). Primary outcome was daily weight gain during the first four months of life, with the difference between the Concept and Control as the key comparison of interest. Additionally, adverse events, growth and tolerance parameters were evaluated. Equivalence of daily weight gain was demonstrated between the Concept and Control group after additional correction for ethnicity and birthweight (difference in estimated means of 0.1 g/d, 90%CI [-2.30, 2.47]; equivalence margin +/- 3 g/d). No clinically relevant group differences were observed in secondary growth outcomes, tolerance outcomes or number, severity or relatedness of adverse events. This study corroborates that an infant formula with large, milk phospholipid-coated lipid droplets supports adequate growth and is well tolerated and safe for use in healthy infants.
引用
收藏
页数:16
相关论文
共 35 条
  • [1] An infant formula with large, milk phospholipid-coated lipid droplets containing a mixture of dairy and vegetable lipids supports adequate growth and is well tolerated in healthy, term infants
    Breij, Laura M.
    Abrahamse-Berkeveld, Marieke
    Vandenplas, Yvan
    Jespers, Sabine N. J.
    de Mol, Amerik C.
    Khoo, Poh Choo
    Kalenga, Masendu
    Peeters, Stefaan
    van Beek, Ron H. T.
    Norbruis, Obbe F.
    Schoen, Stefanie
    Acton, Dennis
    Hokken-Koelega, Anita C. S.
    Thio, B. J.
    Roze, J.
    Calders, A.
    Savagner, C.
    Franckx, J.
    Logghe, K. A. J.
    Rebaud, P.
    van Mil, G. A. H.
    Rajadurai, V. S.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2019, 109 (03): : 586 - 596
  • [2] An Infant Formula with Partially Hydrolyzed Whey Protein Supports Adequate Growth and Is Safe and Well-Tolerated in Healthy, Term Infants: A Randomized, Double-Blind, Equivalence Trial
    Picaud, Jean-Charles
    Pajek, Barbara
    Arciszewska, Malgorzata
    Tarczon, Izabela
    Escribano, Joaquin
    Porcel, Rocio
    Adelt, Thomas
    Hassink, Elly
    Rijnierse, Anneke
    Abrahamse-Berkeveld, Marieke
    Korczowski, Bartosz
    Mazela, Jan
    Schlembach, Dietmar
    Oudshoorn, Annemarie
    Kalach, Nicolas
    Pastor Rosado, Jose
    Closa, Ricardo
    Nermes, Merja
    Laitinen, Kirsi
    NUTRIENTS, 2020, 12 (07) : 1 - 16
  • [3] A partially hydrolyzed formula with synbiotics supports adequate growth and is well tolerated in healthy, Chinese term infants: A double-blind, randomized controlled trial
    Wang, Ying
    Li, Zailing
    Wu, Jie-Ling
    Zhang, Lili
    Liu, Min
    Tan, Meizhen
    Botma, Akke
    Liu, Mengjin
    Mulder, Kelly A.
    Abrahamse-Berkeveld, Marieke
    Cai, Wei
    NUTRITION, 2021, 91-92
  • [4] Formula with large, milk phospholipid-coated lipid droplets in late-moderate preterm infants: a double-blind RCT
    Kakaroukas, Andreas
    Abrahamse-Berkeveld, Marieke
    Hayes, Louise
    McNally, Richard J. Q.
    Berrington, Janet E.
    van Elburg, Ruurd M.
    Embleton, Nicholas D.
    PEDIATRIC RESEARCH, 2024, : 639 - 646
  • [5] A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial
    Kouwenhoven, Stefanie M. P.
    Antl, Nadja
    Finken, Martijn J. J.
    Twisk, Jos W. R.
    van der Beek, Eline M.
    Abrahamse-Berkeveld, Marieke
    van de Heijning, Bert J. M.
    Schierbeek, Henk
    Holdt, Lesca M.
    van Goudoever, Johannes B.
    Koletzko, Berthold, V
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2020, 111 (05): : 962 - 974
  • [6] A Partly Fermented Infant Formula with Postbiotics Including 3′-GL, Specific Oligosaccharides, 2′-FL, and Milk Fat Supports Adequate Growth, Is Safe and Well-Tolerated in Healthy Term Infants: A Double-Blind, Randomised, Controlled, Multi-Country Trial
    Vandenplas, Yvan
    de Halleux, Virginie
    Arciszewska, Malgorzata
    Lach, Piotr
    Pokhylko, Valeriy
    Klymenko, Viktoriia
    Schoen, Stefanie
    Abrahamse-Berkeveld, Marieke
    Mulder, Kelly A.
    Porcel Rubio, Rocio
    NUTRIENTS, 2020, 12 (11) : 1 - 17
  • [7] Evaluation of an Infant Formula with Large, Milk-Phospholipid Coated Lipid Droplets on Long-Term Growth and Development of Singaporean Infants: Randomized Controlled Trial Protocol
    Shek, Lynette P.
    Chong, Yap Seng
    Winokan, Antoinette
    Abrahamse-Berkeveld, Marieke
    Van Der Beek, Eline M.
    Teoh, Oon Hoe
    NUTRIENTS, 2021, 13 (08)
  • [8] Infant formula with added Lacticaseibacillus rhamnosus GG supported adequate growth and was well tolerated in healthy term infants: a randomized controlled trial
    Berseth, Carol Lynn
    Yeiser, Michael
    Harris, Cheryl L.
    Kinnaman, Jennifer N.
    Lappin, Victoria
    Wampler, Jennifer L.
    Zhuang, Weihong
    Vanderhoof, Jon
    FRONTIERS IN PEDIATRICS, 2024, 12
  • [9] Evaluation of an Infant Formula With Large, Milk Phospholipid-Coated Lipid Droplets on Long-Term Growth And Adiposity: The Saturn Study Design
    Dorrepaal, Demi
    van Beijsterveldt, Inge
    Abrahamse-Berkeveld, Marieke
    Hokken, Anita
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 617 - 617
  • [10] A Concept Formula With Large, Milk Phospholipid-Coated Lipid Droplets Enriched With Milk Fat Decreases Palmitic Acid and Calcium Levels in Stools of Healthy, Term Infants
    van de Heijning, Bert J. M.
    Schoen, Stefanie
    Abrahamse-Berkeveld, Marieke
    Hokken-Koelega, Anita C. S.
    van Der Beek, Eline M.
    EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY, 2022, 124 (12)